Abstract
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic disorders characterized by monoclonal plasma cell proliferation in the bone marrow in the absence of end-organ damage. Updated diagnostic criteria for these disorders, risk-stratification models to determine prognosis, and the current management of these two entities are discussed in this review.
Original language | English (US) |
---|---|
Pages (from-to) | 255-265 |
Number of pages | 11 |
Journal | Blood Reviews |
Volume | 21 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2007 |
Keywords
- Monoclonal Gammopathy
- Prognosis
- Smoldering Multiple Myeloma
- Treatment
ASJC Scopus subject areas
- Hematology
- Oncology